Alexandre P. Zavascki

Alexandre P. Zavascki publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Alexandre P. Zavascki sits on this spectrum.

Alexandre P. Zavascki D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Alexandre P. Zavascki sits on this spectrum.

Best Publications

• Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review

  Alexandre Prehn Zavascki;Alexandre Prehn Zavascki;Luciano Zubaran Goldani;Jian Li;Roger L. Nation

  1031
  Citations

• International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

  Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul

  938
  Citations

• Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy

  Alexandre P Zavascki;Cecília G Carvalhaes;Renata C Picão;Ana C Gales

  547
  Citations

• Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

  Ana M Sandri;Cornelia Barbara Landersdorfer;Cornelia Barbara Landersdorfer;Jovan Jacob;Marcio M Boniatti

  470
  Citations

• Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients

  Alexandre P. Zavascki;Luciano Z. Goldani;Guoying Cao;Silvana V. Superti

  267
  Citations

• Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?

  Alexandre P Zavascki;Roger L Nation

  217
  Citations

• Combination therapy for carbapenem-resistant Gram-negative bacteria

  Unknown

  192
  Citations

• Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.

  Unknown

  174
  Citations

• The influence of metallo-β-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections

  Unknown

  160
  Citations

• The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic

  Unknown

  151
  Citations

• Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B

  Unknown

  149
  Citations

• Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.

  Unknown

  146
  Citations

• Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil

  Unknown

  139
  Citations

• Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study

  Unknown

  135
  Citations

• Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.

  Unknown

  125
  Citations

• Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity.

  Roger L. Nation;Maria Helena da Silva Pitombeira Rigatto;Diego Rodrigues Falci;Alexandre Prehn Zavascki

  120
  Citations

• Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-β-lactamase-mediated multidrug resistance: a prospective observational study

  Unknown

  107
  Citations

• Characterization of Tn3000, a transposon responsible for blaNDM-1 dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India

  Juliana Coutinho Campos;Maria José Félix da Silva;Paulo Roberto Nascimento dos Santos;Elaine Menezes Barros

  106
  Citations

• Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections

  Unknown

  93
  Citations

• Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis

  Ana M Sandri;Cornelia Barbara Landersdorfer;Cornelia Barbara Landersdorfer;Jovan Jacob;Marcio M Boniatti

  92
  Citations